Related Experiment Video

Updated: Aug 11, 2026

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
05:57

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study

Gavin Rukholm1, Clement Mugabe, Ali O Azghani

  • 1The Novel Drug and Vaccine Delivery Systems Facility, Department of Chemistry and Biochemistry, Laurentian University, 935 Ramsey Lake Road, Sudbury, Ont., Canada P3E 2C6.

International Journal of Antimicrobial Agents
|February 14, 2006
PubMed

Insights

Liposome-encapsulated gentamicin shows enhanced effectiveness against Pseudomonas aeruginosa infections common in cystic fibrosis. This formulation offers improved killing time and prolonged antimicrobial activity compared to free gentamicin.

Area of Science:

  • Pharmacology
  • Microbiology
  • Drug Delivery

Background:

  • Cystic fibrosis (CF) is a genetic disorder leading to chronic Pseudomonas aeruginosa infections.
  • Aminoglycoside antibiotics like gentamicin are effective but toxic.
  • Liposomal encapsulation is a strategy to improve antibiotic delivery and reduce toxicity.

Purpose of the Study:

  • To compare the bactericidal efficacy of liposome-encapsulated gentamicin versus free gentamicin against P. aeruginosa.
  • To determine the physicochemical properties and antimicrobial activity of the liposomal formulation.

Main Methods:

  • Determined liposome size, encapsulation efficiency, and minimal inhibitory concentrations (MICs) for free and liposomal gentamicin.
  • Conducted in vitro time-kill studies using P. aeruginosa isolates exposed to varying concentrations of both formulations.

Main Results:

  • Liposomal gentamicin exhibited significantly lower MICs compared to free gentamicin.
  • Time-kill studies demonstrated equivalent or superior bacterial killing with liposomal gentamicin.
  • The liposomal formulation had an average size of 426.25 nm and 4.51% encapsulation efficiency.

Conclusions:

  • Liposomal gentamicin is a more potent antipseudomonal agent.
  • This formulation offers improved killing time and prolonged antimicrobial activity.
  • Liposomal encapsulation represents a promising strategy to enhance gentamicin efficacy in treating P. aeruginosa infections.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...